Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Clinical trial NCT00686920 · COMPLETED

Trial details

NCT number: NCT00686920
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatic Encephalopathy

Start date: 2007-03-07
Primary completion: 2010-12-08
Enrollment: 322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.